Identify assets for potential acquisition/licensing opportunities in line with the organization’s strategy
A large pharma/biotech company wanted to Identify potential acquisition/licensing candidates that fit with the organization’s strategic, commercial, and development objectives.
Viscadia focused on differentiated assets with strong IP, exclusive market access, or hospital positioning. Priority was given to assets capable of quick revenue generation or with clear paths to monetization.
Assets already on the market or in late-stage development, likely to gain regulatory approval, were sought. Preference was for assets leveraging the organization’s sales force and expertise for amplified impact. Viscadia identified assets aligning with the organization’s long-term vision, ensuring a strong foundation for future healthcare sector growth and success.